Defence Therapeutics (QB) Stock Quote DTCFF - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.2732

Bid

0.20

Ask

0.7468

Volume

0.00 Day's Range 0.00

0.2732 52 Week Range 1.738

Market Cap

13.018M

Previous Close

0.2732

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

679

Shares Outstanding

47,650,370

Dividend Yield

PE Ratio

-0.98

Earnings Per Share (EPS)

-0.28

Revenue

Net Profit

-13.19M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.defencetherapeutics.com

Headquarters

Vancouver, British Columbia, Can

Founded

Defence Therapeutics Inc (QB) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker DTCFF. The last closing price for Defence Therapeutics (QB) was $0.27. Over the last year, Defence Therapeutics (QB) shares have traded in a share price range of $ 0.2732 to $ 1.738.

Defence Therapeutics (QB) currently has 47,650,370 shares outstanding. The market capitalization of Defence Therapeutics (QB) is $13.02 million. Defence Therapeutics (QB) has a price to earnings ratio (PE ratio) of -0.98.

DEFENCE RETAINS CATO SMS TO ADVISE ON ITS PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER

DEFENCE RETAINS CATO SMS TO ADVISE ON ITS PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER Vancouver, BC, Canada, February 16th, 2022 -- InvestorsHub NewsWire Defence Therapeutics Inc...

Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9

Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9 Vancouver, BC, Canada, January 26th...

DEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENT

Vancouver, BC, Canada -- November 30th 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. (CSE: DTC; FSE: DTC; USOTC: DTCFF) ("Defence" or the...

DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER

DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER Vancouver, BC, Canada -- November 23, 2021 -- InvestorsHub NewsWire...

DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS

DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS Vancouver, BC, Canada, November 9th, 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. CSE:DTC, USOTC:DTCFF...

VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS

VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS Vancouver, BC, Canada, November...

DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER

DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER Vancouver, BC, Canada, October 13th...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	-0.14026	-33.9234750641	0.41346	0.41346	0.2732	100	0.34333	CS
12	-0.13654	-33.3235710451	0.40974	0.4361	0.2732	679	0.41217026	CS
26	-0.2991	-52.2627992312	0.5723	0.6607	0.2732	911	0.49411653	CS
52	-1.3768	-83.4424242424	1.65	1.738	0.2732	805	0.81330939	CS
156	-3.9768	-93.5717647059	4.25	4.47	0.2732	1005	1.75341377	CS
260	-2.2268	-89.072	2.5	6.4078	0.2732	1186	2.81663998	CS

DTCFF - Frequently Asked Questions (FAQ)

What is the current Defence Therapeutics (QB) share price?

The current share price of Defence Therapeutics (QB) is $ 0.2732

How many Defence Therapeutics (QB) shares are in issue?

Defence Therapeutics (QB) has 47,650,370 shares in issue

What is the market cap of Defence Therapeutics (QB)?

The market capitalisation of Defence Therapeutics (QB) is USD 13.02M

What is the 1 year trading range for Defence Therapeutics (QB) share price?

Defence Therapeutics (QB) has traded in the range of $ 0.2732 to $ 1.738 during the past year

What is the PE ratio of Defence Therapeutics (QB)?

The price to earnings ratio of Defence Therapeutics (QB) is -0.98

What is the reporting currency for Defence Therapeutics (QB)?

Defence Therapeutics (QB) reports financial results in CAD

What is the latest annual profit for Defence Therapeutics (QB)?

The latest annual profit of Defence Therapeutics (QB) is CAD -13.19M

What is the registered address of Defence Therapeutics (QB)?

The registered address for Defence Therapeutics (QB) is 1680 - 200 BURRARD STREET, VANCOUVER, BRITISH COLUMBIA, V6C 3L6

What is the Defence Therapeutics (QB) website address?

The website address for Defence Therapeutics (QB) is www.defencetherapeutics.com

Which industry sector does Defence Therapeutics (QB) operate in?

Defence Therapeutics (QB) operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
RAASYCloopen Group Holding Limited (CE)	$ 0.05 (4,999,900.00%)	1.59k
NEPTFNeptune Wellness Solutions Inc (CE)	$ 0.015 (1,499,900.00%)	3.35k
HAVLFHavn Life Sciences Inc (CE)	$ 0.001 (99,900.00%)	15.17k
STTOSITO Mobile Ltd (CE)	$ 0.0012 (59,900.00%)	500
LTFDLittlefield Corporation (CE)	$ 0.11 (36,566.67%)	1.8k
PRMDPrimeMD Inc (CE)	$ 0.000001 (-99.67%)	200
NEOMNeoMedia Technologies Inc (CE)	$ 0.000001 (-99.50%)	75.34k
AMINAmerican International Industries Inc (CE)	$ 0.0001 (-99.50%)	1,000
SDCCQSmileDirectClub Inc (CE)	$ 0.000001 (-99.00%)	220.31k
MAPTMAPtelligent Inc (CE)	$ 0.000001 (-99.00%)	165k
PHILPHI Group Inc (PK)	$ 0.0005 (66.67%)	539.33M
HMBLHUMBL Inc (PK)	$ 0.0008 (0.00%)	282.78M
RDARRaadr Inc (PK)	$ 0.0017 (25.93%)	220.95M
GRLFGreen Leaf Innovations Inc (PK)	$ 0.0001 (0.00%)	185.17M
TSOITherapeutic Solutions International Inc (PK)	$ 0.0002 (-33.33%)	172.87M